Skip to Main Content

Advertisement

Skip Nav Destination

Abstract P5-19-11: Noninterventional study HELENA – Advanced (metastatic or locally recurrent, inoperable) HER2-positive breast cancer: First-Line trEatmeNt with pertuzumAb after adjuvant trastuzumab therapy

Cancer Res (2015) 75 (9_Supplement): P5-19-11.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal